市场调查报告书

病毒学市场预测:各种类、用途、终端用户、地区

Virology Market: By Type ; By Application ; By End-User & By Region - 2019-2023

出版商 IndustryARC 商品编码 422720
出版日期 内容资讯 英文
商品交期: 2-3个工作天内
价格
Back to Top
病毒学市场预测:各种类、用途、终端用户、地区 Virology Market: By Type ; By Application ; By End-User & By Region - 2019-2023
出版日期: 2018年12月15日内容资讯: 英文
简介

本报告提供病毒学市场相关调查,推动、阻碍市场要素和市场机会,各种类、用途、终端用户、地区的市场趋势分析、预测,市场熵和以及主要企业的简介等汇整。

第1章 病毒学市场概要

第2章 摘要整理

第3章 病毒学市场情势

  • 市场占有率分析
  • 竞争分析
  • 产品基准
  • 终端用户简介
  • 前五名公司的财务分析

第4章 市场动态

  • 市场推动因素
  • 市场阻碍因素
  • 市场机会
  • 波特的五力分析

第5章 策略分析

  • 价值链分析
  • 价格分析
  • 机会分析
  • 产品及市场生命周期分析
  • 供应商、发行者

第6章 病毒学市场:各类型

  • 诊断试验
  • 病毒性行为感染管理
  • 抗病毒化疗
  • 病毒抑制因素

第7章 病毒学市场:各用途

  • 皮肤、软组织感染疾病
  • 呼吸道感染疾病
  • 消化器官感染疾病
  • 泌尿道感染
  • 眼感染疾病
  • 中枢神经感染疾病
  • 性感染疾病
  • 周产期感染疾病

第8章 病毒学市场:各终端用户

  • 医院
  • 诊疗所
  • 临床研究设施
  • 诊断中心
  • 血库
  • 药局

第9章 病毒学市场:各地区

  • 欧洲
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 英国
    • 其他
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他
  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 其他地区(RoW)
    • 巴西
    • 其他

第10章 病毒学市场:熵

  • 市场扩大
  • 技术的进步
  • 合并、收购、合资企业
  • 供给、契约

第11章 企业简介

第12章 附录

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录

The global virology market is estimated at $1693 million in 2017 and is estimated to grow at a CAGR of 5.4% during the forecast period 2018-2023. North America is the leading market holder driven by world class healthcare substructure with technological advancement practice. Asia-Pacific is likely attaining highest growth due to growing healthcare tourism in the nations of China and India. Hospitals and the Laboratories are the most dominating end-use segments

What is virology?

Virology is the scientific discipline concerned with the study of the microbiological or pathological science which involves the study of viruses and viral diseases, including the distribution, biochemistry, disease producing properties, physiology, molecular biology, ecology, cultivation, evolution, genetics and clinical aspects of viruses. Virology explain about the interaction with host organism physiology and immunity, the diseases they cause, the techniques to isolate and culture them, ways to infect and exploit host cells for reproduction, and their use in research and therapy.

Market Research and Market Trends of virology market

Notable advances in nanotechnology, nanostructure-based electrical sensors have been emerged as promising platforms for real-time, sensitive detection of numerous bioanalytes. Using Nanopore-Based Resistive-Pulse Sensing Techniques, scientists are determining both the dimensions and the number of viruses. So, this provides important complementary information and detect all viruses and virus related particles.

Microbiology testing considered as one of the most rapidly growing segments in the diagnostics industry. The major driving forces for this include continuous spread of HIV, which is the world's major health threat and is a key factor contributing to the rise in opportunistic infections, bioterrorism, advances in molecular diagnostic technologies, and a wider availability of immune suppressive drug.

Awareness programs about various viruses such as Ebola virus, Flu, Zika virus, STD's, AIDS are the key factor increasing people awareness and eventually increasing the market growth by employing the virology applications.

Who are the Major Players in virology market?

The companies referred in the market research report includes GlaxoSmithKline plc, Abbott Laboratories, Boehringer Ingelheim Corporation, Merck and Co. Inc., Novartis International AG.

What is our report scope?

The report incorporates in-depth assessment of the competitive landscape, product market sizing, product benchmarking, market trends, product developments, financial analysis, strategic analysis and so on to gauge the impact forces and potential opportunities of the market. Apart from this the report also includes a study of major developments in the market such as product launches, agreements, acquisitions, collaborations, mergers and so on to comprehend the prevailing market dynamics at present and its impact during the forecast period 2018-2024.

All our reports are customizable to your company needs to a certain extent, we do provide 20 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report to your needs.

Key Takeaways from this Report

Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.

Understand the different dynamics influencing the market - key driving factors, challenges and hidden opportunities.

Get in-depth insights on your competitor performance - market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.

Analyze the sales and distribution channels across key geographies to improve top-line revenues.

Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.

Get a quick outlook on the market entropy - M's, deals, partnerships, product launches of all key players for the past 4 years.

Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.

1. Virology Market - Overview

2. Executive Summary

3. Virology Market Landscape

  • 3.1. Market Share Analysis
  • 3.2. Comparative Analysis
  • 3.3. Product Benchmarking
  • 3.4. End User Profiling
  • 3.5. Top 5 Financials Analysis

4. Virology Market- Forces

  • 4.1. Drivers
    • 4.1.1. Increasing incidences of global viral epidemics
    • 4.1.2. Growing applications of virology research in gene therapy, phage therapy, formulation of vaccines, and synthetic biology
  • 4.2. Restraints
  • 4.3. Opportunities
  • 4.4. Challenges
  • 4.5. Porter's Five Forces Analysis
    • 4.5.1. Bargaining Power of Suppliers
    • 4.5.2. Bargaining Power of Buyers
    • 4.5.3. Threat of New Entrants
    • 4.5.4. Threat of Substitutes
    • 4.5.5. Degree of Competition

5. Virology Market- Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Opportunities Analysis
  • 5.4. Product/Market Life Cycle Analysis
  • 5.5. Suppliers and Distributors

6. Virology Market, By Type

  • 6.1. Diagnosing Test
  • 6.2. Viral Infection Controlling Methods
  • 6.3. Antiviral Chemotherapy
  • 6.4. Interferons

7. Virology Market, By Application

  • 7.1. Skin and Soft Tissue Infections
  • 7.2. Respiratory Tract Infections
  • 7.3. GI Tract Infections
  • 7.4. Urinary Tract Infections
  • 7.5. Eye Infections
  • 7.6. CNS Infections
  • 7.7. Sexually Transmitted Diseases
  • 7.8. Perinatal Infections

8. Virology Market, By End-User

  • 8.1. Hospitals
  • 8.2. Clinics
  • 8.3. Laboratories
  • 8.4. Diagnostic Centres
  • 8.5. Blood Banks
  • 8.6. Pharmacies

9. Virology Market, By Geography

  • 9.1. Europe
    • 9.1.1. Germany
    • 9.1.2. France
    • 9.1.3. Italy
    • 9.1.4. Spain
    • 9.1.5. Russia
    • 9.1.6. U.K.
    • 9.1.7. Rest of Europe
  • 9.2. Asia Pacific
    • 9.2.1. China
    • 9.2.2. India
    • 9.2.3. Japan
    • 9.2.4. South Korea
    • 9.2.5. Rest of Asia-Pacific
  • 9.3. North America
    • 9.3.1. U.S.
    • 9.3.2. Canada
    • 9.3.3. Mexico
  • 9.4. Rest of the World (RoW)
    • 9.4.1. Brazil
    • 9.4.2. Rest of RoW

10. Virology Market - Entropy

  • 10.1. Expansion
  • 10.2. Technological Developments
  • 10.3. Merger & Acquisitions, and Joint Ventures
  • 10.4. Supply- Contract

11. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)

  • 11.1. GlaxoSmithKline plc
  • 11.2. Abbott Laboratories
  • 11.3. Boehringer Ingelheim Corporation
  • 11.4. Merck and Co. Inc.
  • 11.5. Novartis International AG
  • 11.6. Siemens
  • 11.7. Johnson & Johnson
  • 11.8. AstraZeneca AB
  • 11.9. Roche
  • 11.10. Abivax

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

12. Appendix

  • 12.1. Abbreviations
  • 12.2. Sources
  • 12.3. Research Methodology
  • 12.4. Bibliography
  • 12.5. Compilation of Expert Insights
  • 12.6. Disclaimer
Back to Top